KKR announced the final close of its North America Fund XIV at approximately $23 billion, marking the firm’s largest private…
Read More
SF biotech company, once worth nearly $1 billion, to shut down
After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more…
Read More
KKR Closes $23 Billion North America Private Equity Fund
KKR, a leading global investment firm, today announced the final closing of KKR North America Fund XIV, an approximately $23…
Read More
Two Brothers, AI, and a $1.8 Billion Valuation
A two-person startup just hit a $1.8 billion valuation by letting artificial ininformigence handle nearly every operational tinquire that traditionally…
Read More
NBA Europe attracts US$1 billion bids, with more than 120 investors revealing keen interest
The National Bquestionetball Association (NBA) has received offers of more than US$1 billion for the right to play in its…
Read More
Frozen Russian assets — Where the €1.4 billion in profits for Ukraine will go
Where the money comes from The funds come from interest accrued on cash balances generated by assets of the Central…
Read More
NBA Europe Team Bids Include Multiple $1 Billion Offers
First-round bids for teams in the new NBA Europe were due Tuesday, and multiple bidders offered $1 billion to be…
Read More
India’s venture capital funding at $16 billion in 2025, deal activity surges 18 pc
New Delhi, April 1 (IANS) India’s venture capital ecosystem raised roughly $16 billion in 2025 and saw deal activity grow…
Read More
Bay Area biotech company worth $10 billion lays off 130 workers
Exelixis, a high-flying biotech company that creates anti-cancer drugs in Alameda, is laying off 130 workers. The company’s cuts were…
Read More
A $1.2 Billion Strategic Blueprint
The Australian counter-drone specialist is decisively shifting its operational center of gravity toward Europe. This strategic realignment is marked by…
Read More
